Design, synthesis, molecular modeling and biological evaluation of novel diaryl heterocyclic analogs as potential selective cyclooxygenase-2 (COX-2) inhibitors

被引:14
|
作者
Al-Turki, Deema A. [1 ]
Al-Omar, Mohamed A. [1 ]
Abou-zeid, Laila A. [2 ]
Shehata, Ihsan A. [4 ]
Al-Awady, Mohammed S. [3 ]
机构
[1] King Saud Univ, Coll Pharm, Dept Pharmaceut Chem, POB 2457, Riyadh 11451, Saudi Arabia
[2] Mansoura Univ, Dept Organ Pharmaceut Chem, Fac Pharm, Mansoura 35516, Egypt
[3] Mansoura Univ, Dept Pharmacol, Fac Pharm, Mansoura 35516, Egypt
[4] Mansoura Univ, Dept Med Chem, Fac Pharm, Mansoura 35516, Egypt
关键词
Selective COX-2 inhibitors; Docking; Synthesis; Anti-inflammatory; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; GASTROINTESTINAL COMPLICATIONS; RISK; STRATEGIES; AGENTS; NSAIDS;
D O I
10.1016/j.jsps.2015.07.001
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
New series of 3,4-diaryl-2-thioxoimidazolidin-4-ones and 3-alkylthio-4,5-diaryl-4H-1,2,4-triazoles were designed, synthesized and evaluated for their activity as anti-inflammatory agents. Compounds 20, 21, 23 and 34 are highly selective inhibitors of COX-2 enzyme at a concentration of 100 mM relative to celecoxib, the standard reference. (+/-)-3-(4-Phenoxy-phenyl)-5-phenyl-2-thioxoimidazolidin-4-ones 23 exhibited the most active anti-inflammatory agent. (C) 2015 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:59 / 69
页数:11
相关论文
共 50 条
  • [1] Synthesis, molecular modeling and biological evaluations of novel pyrrolidine derivatives as potential cyclooxygenase-2 (COX-2) inhibitors
    Kamlesh H. Chavan
    Nathrao Ankushrao Kedar
    Ashish M. Kanhed
    Vishal Kumar Agrahari
    Anshuman Sinha
    [J]. Journal of the Iranian Chemical Society, 2021, 18 : 1801 - 1813
  • [2] Synthesis, molecular modeling and biological evaluations of novel pyrrolidine derivatives as potential cyclooxygenase-2 (COX-2) inhibitors
    Chavan, Kamlesh H.
    Kedar, Nathrao Ankushrao
    Kanhed, Ashish M.
    Agrahari, Vishal Kumar
    Sinha, Anshuman
    [J]. JOURNAL OF THE IRANIAN CHEMICAL SOCIETY, 2021, 18 (07) : 1801 - 1813
  • [3] Synthesis, biological evaluation, and docking studies of novel heterocyclic diaryl compounds as selective COX-2 inhibitors
    Eren, Goekcen
    Unlu, Serdar
    Nunez, Maria-Teresa
    Labeaga, Luis
    Ledo, Francisco
    Entrena, Antonio
    Banoglu, Erden
    Costantino, Gabriele
    Sahin, M. Fethi
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (17) : 6367 - 6376
  • [4] Synthesis and evaluation of 1,5-diaryl-substituted tetrazoles as novel selective cyclooxygenase-2 (COX-2) inhibitors
    Al-Hourani, Baker Jawabrah
    Sharma, Sai Kiran
    Mane, Jonathan Y.
    Tuszynski, Jack
    Baracos, Vickie
    Kniess, Torsten
    Suresh, Mavanur
    Pietzsch, Jens
    Wuest, Frank
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (06) : 1823 - 1826
  • [5] Design and synthesis of novel diaryl heterocyclic derivatives as selective cyclooxygenase-2
    Li, S. X.
    Deng, X. D.
    Jiang, F. L.
    Zhao, Y. J.
    Xiao, W. S.
    Kuang, X. Z.
    Sun, X. M.
    [J]. LETTERS IN DRUG DESIGN & DISCOVERY, 2008, 5 (02) : 127 - 133
  • [6] Design, synthesis, and biological evaluation of N-acetyl-2-carboxybenzenesulfonamides:: a novel class of cyclooxygenase-2 (COX-2) inhibitors
    Chen, QH
    Rao, PNP
    Knaus, EE
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (07) : 2459 - 2468
  • [7] Synthesis of novel pyrazole-thiadiazole hybrid as potential potent and selective cyclooxygenase-2 (COX-2) inhibitors
    Alegaon, S. G.
    Hirpara, M. B.
    Alagawadi, K. R.
    Hullatti, K. K.
    Kashniyal, K.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (22) : 5324 - 5329
  • [8] Selective cyclooxygenase-2 (COX-2) inhibitors and potential risk of cardiovascular events
    Mukherjee, D
    [J]. BIOCHEMICAL PHARMACOLOGY, 2002, 63 (05) : 817 - 821
  • [9] Comparative molecular field analysis of selective cyclooxygenase-2 (COX-2) inhibitors
    Marot, C
    Chavatte, P
    Lesieur, D
    [J]. QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIPS, 2000, 19 (02): : 127 - 134
  • [10] Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors
    Groesch, Sabine
    Maier, Thorsten Juergen
    Schiffmann, Susanne
    Geisslinger, Gerd
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (11) : 736 - 747